David Jiménez1, Fernando Uresandi2, Remedios Otero3, José Luis Lobo4, Manuel Monreal5, David Martí6, Javier Zamora7, Alfonso Muriel7, Drahomir Aujesky8, Roger D Yusen9. 1. Respiratory Department, Ramón y Cajal Hospital, Madrid, Spain. Electronic address: djc_69_98@yahoo.com. 2. Respiratory Department, Cruces Hospital, Bilbao, Spain. 3. Respiratory Department, Virgen del Rocío Hospital, Sevilla, Spain. 4. Respiratory Department, Txagorritxu Hospital, Vitoria, Spain. 5. Medicine Department, Germans Trias i Pujol Hospital, Barcelona, Spain. 6. Cardiology Department, Ramón y Cajal Hospital, Madrid, Spain. 7. Biostatistics Unit, Ramón y Cajal Hospital, Madrid, Spain. 8. Division of General Internal Medicine, University of Lausanne, Lausanne, Switzerland. 9. Divisions of Pulmonary and Critical Care Medicine and General Medical Sciences, Washington University School of Medicine, St. Louis, MO.
Abstract
BACKGROUND: Controversy exists regarding the usefulness of troponin testing for the risk stratification of patients with acute pulmonary embolism (PE). We conducted an updated systematic review and a metaanalysis of troponin-based risk stratification of normotensive patients with acute symptomatic PE. The sources of our data were publications listed in Medline and Embase from 1980 through April 2008 and a review of cited references in those publications. METHODS: We included all studies that estimated the relation between troponin levels and the incidence of all-cause mortality in normotensive patients with acute symptomatic PE. Two reviewers independently abstracted data and assessed study quality. From the literature search, 596 publications were screened. Nine studies that consisted of 1,366 normotensive patients with acute symptomatic PE were deemed eligible. Pooled results showed that elevated troponin levels were associated with a 4.26-fold increased odds of overall mortality (95% CI, 2.13 to 8.50; heterogeneity chi(2) = 12.64; degrees of freedom = 8; p = 0.125). Summary receiver operating characteristic curve analysis showed a relationship between the sensitivity and specificity of troponin levels to predict overall mortality (Spearman rank correlation coefficient = 0.68; p = 0.046). Pooled likelihood ratios (LRs) were not extreme (negative LR, 0.59 [95% CI, 0.39 to 0.88]; positive LR, 2.26 [95% CI, 1.66 to 3.07]). The Begg rank correlation method did not detect evidence of publication bias. CONCLUSIONS: The results of this metaanalysis indicate that elevated troponin levels do not adequately discern normotensive patients with acute symptomatic PE who are at high risk for death from those who are at low risk for death.
BACKGROUND: Controversy exists regarding the usefulness of troponin testing for the risk stratification of patients with acute pulmonary embolism (PE). We conducted an updated systematic review and a metaanalysis of troponin-based risk stratification of normotensive patients with acute symptomatic PE. The sources of our data were publications listed in Medline and Embase from 1980 through April 2008 and a review of cited references in those publications. METHODS: We included all studies that estimated the relation between troponin levels and the incidence of all-cause mortality in normotensive patients with acute symptomatic PE. Two reviewers independently abstracted data and assessed study quality. From the literature search, 596 publications were screened. Nine studies that consisted of 1,366 normotensive patients with acute symptomatic PE were deemed eligible. Pooled results showed that elevated troponin levels were associated with a 4.26-fold increased odds of overall mortality (95% CI, 2.13 to 8.50; heterogeneity chi(2) = 12.64; degrees of freedom = 8; p = 0.125). Summary receiver operating characteristic curve analysis showed a relationship between the sensitivity and specificity of troponin levels to predict overall mortality (Spearman rank correlation coefficient = 0.68; p = 0.046). Pooled likelihood ratios (LRs) were not extreme (negative LR, 0.59 [95% CI, 0.39 to 0.88]; positive LR, 2.26 [95% CI, 1.66 to 3.07]). The Begg rank correlation method did not detect evidence of publication bias. CONCLUSIONS: The results of this metaanalysis indicate that elevated troponin levels do not adequately discern normotensive patients with acute symptomatic PE who are at high risk for death from those who are at low risk for death.
Authors: Sven F Thieme; Nima Ashoori; Fabian Bamberg; Wieland H Sommer; Thorsten R C Johnson; Hanno Leuchte; Alexander Becker; Daniel Maxien; Andreas D Helck; Jürgen Behr; Maximilian F Reiser; Konstantin Nikolaou Journal: Eur Radiol Date: 2011-09-14 Impact factor: 5.315
Authors: Yu Lin Chen; Colin Wright; Anthony P Pietropaoli; Ayman Elbadawi; Joseph Delehanty; Bryan Barrus; Igor Gosev; David Trawick; Dhwani Patel; Scott J Cameron Journal: J Thromb Thrombolysis Date: 2020-01 Impact factor: 2.300